Related Experiment Video
Updated: Sep 1, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Low-Dose Heparin Protocol in Type A Aortic Dissection Surgeries
Levent Mavioglu1, Mehmet Karahan1, Ertekin Utku Unal2
1Department of Cardiovascular Surgery, Yuksek Ihtisas Cardiovascular Hospital, Ankara City Hospital Complex, Ankara, Turkey.
Insights
A low-dose heparin protocol significantly reduced postoperative bleeding and red blood cell transfusions in type A aortic dissection (TAAD) surgery compared to the standard-dose regimen. This finding suggests a safer approach for TAAD patients.
Area of Science:
- Cardiovascular Surgery
- Anesthesiology
- Hematology
Background:
- Type A aortic dissection (TAAD) is a life-threatening condition requiring complex surgical intervention.
- Heparin administration is crucial during TAAD surgery but carries a risk of bleeding complications.
- Optimizing heparin dosage is essential to balance anticoagulation needs with hemostasis.
Purpose of the Study:
- To compare the efficacy and safety of standard-dose heparin (SH) versus low-dose heparin (LH) protocols in patients undergoing TAAD surgery.
- To evaluate the impact of different heparin regimens on postoperative bleeding, reoperation rates, and blood product transfusion requirements.
Main Methods:
- A pre- and post-implementation study involving 90 adult patients with TAAD between January 2018 and August 2021.
- Patients were divided into two groups: SH group (before October 2019) and LH group (after November 2019).
- Primary outcomes included postoperative bleeding volume and blood product transfusion needs; secondary outcomes included ventilation duration, ICU/hospital stay, drainage, reoperations, and mortality.
Main Results:
- Significant differences were observed in heparin dosage and activated clotting time between the groups (p < 0.001).
- The LH group required standard-dose heparinization in only 33.3% of cases.
- Postoperative total drainage and red blood cell (RBC) transfusions were significantly lower in the LH group compared to the SH group (p = 0.036 and p = 0.046, respectively).
Conclusions:
- The low-dose heparin regimen is associated with significantly reduced postoperative total drainage.
- Low-dose heparin significantly decreases the requirement for RBC transfusions in TAAD patients.
- This study supports the use of a low-dose heparin protocol for improved outcomes in type A aortic dissection surgery.
Objective:
We aim to compare the heparin dose regimen in terms of bleeding, reoperation rate due to severe bleeding, and the amount of transfusion of the blood products in patients who underwent surgery for type A aortic dissection (TAAD).
Materials And Methods:
Between January 2018 and August 2021, 90 adult patients who underwent for TAAD were included. Primary outcome measures were postoperative bleeding amount and blood product transfusion requirements. Two different protocols performed in TAAD surgery in our clinic. In this pre- and postimplementation study, before October 2019, the standard-dose heparin protocol (SH group) was used and after November 2019, the low-dose heparin protocol (LH group) was used and two groups were compared. Mechanical ventilation duration, length of intensive care unit and hospital stay, postoperative drainage volumes, blood product transfusions, reoperations due to bleeding, and in-hospital mortality rates were recorded.
Results:
The dosages of heparin and activated clotting time values, as well as the additional heparin requirement, were significantly different between the two groups (p < 0.001). Standard-dose heparinization was needed only in 33.3% of patients in the LH group. In the SH group, postoperative total drainage and red blood cell (RBC) transfusion were significantly higher than the LH group (p = 0.036 and p = 0.046, respectively).
Conclusion:
We found that the low-dose heparin regimen resulted in significantly less postoperative total drainage and RBC transfusion requirement in patients who underwent for TAAD.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Aneurysm IV: Nursing Management
Aneurysm III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care

